Journal rankings · indicator year 2003
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2003
Biochemistry, Genetics and Molecular Biology journal rankings 2003
742 ranked journals · Field in Life Sciences
Biochemistry, Genetics and Molecular Biology has 742 ranked journals in 2003. The median OJR rose 0.08 on 2002 to 0.76, below the world average of 1.00; Q1 starts at OJR 1.25. The top three are Pharmacological Reviews, Cell, and Annual Review of Plant Physiology and Plant Molecular Biology.
Ranks and citation indicators: 2003. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2000–2002, the window the 2003 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Biochemistry, Genetics and Molecular Biology (14)
Up to Life Sciences742 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2002. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2000–2002, the window the 2003 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2000–2002 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2003. | Compare |
|---|---|---|---|---|---|---|---|
1Pharmacological ReviewsAmerican Society for Pharmacology and Experimental Therapeutics · United States | 11.37Q1 | 21.33 0.24 down from 2002 | 76 | 5% | $4,500 | ||
2CellCell Press · United States | 9.40Q1 | 25.19 0.27 down from 2002 | 1,206 | 94% | $11,400 | ||
3Annual Review of Plant Physiology and Plant Molecular BiologyAnnual Reviews · United States | 8.60Q1 | 18.50 2.79 up from 2002 | 48 | 50% | — | ||
4Nature GeneticsNature Portfolio · United States | 7.17Q1 | 16.91 1.40 down from 2002 | 1,088 | 16% | $12,690 | ||
5NatureNature Portfolio · United Kingdom | 6.99Q1 | 10.77 0.28 up from 2002 | 9,010 | 13% | $12,690 | ||
6Annual Review of Biophysics and Biomolecular StructureAnnual Reviews · United States | 6.22Q1 | 13.92 2.23 down from 2002 | 59 | 5% | — | ||
7Nature Cell BiologyNature Portfolio · United Kingdom | 5.14Q1 | 14.04 0.08 up from 2002 | 820 | 15% | $12,690 | ||
8Molecular CellElsevier BV · United States | 5.10Q1 | 14.54 1.46 down from 2002 | 896 | 92% | $10,400 | ||
9Progress in Lipid ResearchElsevier BV · United Kingdom | 4.96Q1 | 11.78 2.87 up from 2002 | 55 | 0% | $5,530 | ||
10Recent Progress in Hormone ResearchOAEndocrine Society · United States | 4.95Q1 | 9.67 2.33 up from 2002 | 33 | 100% | — | ||
11ScienceAmerican Association for the Advancement of Science · United States | 4.53Q1 | 6.71 0.78 up from 2002 | 13,648 | 4% | — | ||
12Developmental CellElsevier BV · United States | 4.35Q1 | 12.30 4.15 up from 2002 | 298 | 100% | $10,400 | ||
13Proceedings of the National Academy of SciencesNational Academy of Sciences · United States | 4.33Q1 | 10.56 0.12 up from 2002 | 8,793 | 98% | — | ||
14The EMBO JournalOASpringer Nature · Germany | 4.06Q1 | 11.50 0.21 up from 2002 | 2,076 | 96% | $7,990 | ||
15The American Journal of Human GeneticsElsevier BV · United States | 3.99Q1 | 10.75 1.87 up from 2002 | 1,233 | 76% | $5,150 | ||
16Circulation ResearchLippincott Williams & Wilkins · United States | 3.75Q1 | 9.60 0.82 up from 2002 | 1,166 | 54% | — | ||
17Journal of Clinical InvestigationOAAmerican Society for Clinical Investigation · United States | 3.73Q1 | 8.52 2.20 down from 2002 | 2,393 | 77% | $5,200 | ||
18Nature BiotechnologyNature Portfolio · United States | 3.63Q1 | 7.80 1.95 up from 2002 | 1,260 | 15% | $12,690 | ||
19Human Molecular GeneticsOxford University Press · United Kingdom | 3.60Q1 | 9.74 0.07 up from 2002 | 1,026 | 25% | $4,390 | ||
20FEMS Microbiology ReviewsOAOxford University Press · Netherlands | 3.54Q1 | 6.88 0.77 up from 2002 | 180 | 59% | $3,297 | ||
21The Journal of Cell BiologyRockefeller University Press · United States | 3.41Q1 | 9.22 1.91 down from 2002 | 1,850 | 99% | — | ||
22Biochimica et Biophysica Acta (BBA) - Reviews on CancerElsevier BV · Netherlands | 3.35Q1 | 9.18 2.59 up from 2002 | 68 | 0% | $5,070 | ||
23Systematic BiologyOxford University Press · United States | 3.31Q1 | 5.33 0.91 up from 2002 | 298 | 40% | $2,166 | ||
24TrAC Trends in Analytical ChemistryElsevier BV · Netherlands | 3.03Q1 | 3.24 0.07 down from 2002 | 240 | 5% | $5,150 | ||
25Journal of Computational BiologyMary Ann Liebert, Inc. · United States | 2.98Q1 | 7.08 0.80 up from 2002 | 140 | 2% | — | ||
26Pharmacology & TherapeuticsElsevier BV · United States | 2.94Q1 | 7.18 1.80 up from 2002 | 211 | 4% | $5,660 | ||
27Medicinal Research ReviewsWiley · United States | 2.92Q1 | 8.37 3.07 up from 2002 | 98 | 6% | $4,980 | ||
28Molecular & Cellular ProteomicsOAElsevier BV · United States | 2.87Q1 | 6.25no 2002 value | 109 | 94% | $3,430 | — | |
29Cellular MicrobiologyOAWiley · United Kingdom | 2.85Q1 | 5.79 0.40 up from 2002 | 204 | 60% | $2,350 | ||
30American Journal Of PathologyElsevier BV · United States | 2.85Q1 | 6.90 0.25 up from 2002 | 1,422 | 99% | $2,800 | ||
31Progress in Biophysics and Molecular BiologyElsevier BV · United Kingdom | 2.79Q1 | 4.51 0.72 down from 2002 | 58 | 98% | $4,260 | ||
32Molecular and Cellular BiologyTaylor & Francis · United States | 2.77Q1 | 8.66 0.10 down from 2002 | 2,641 | 100% | — | ||
33BioinformaticsOAOxford University Press · United Kingdom | 2.77Q1 | 8.22 2.29 up from 2002 | 801 | 54% | $3,989 | ||
34Annual Review of BiochemistryAnnual Reviews · United States | 2.74Q1 | 41.12 2.71 up from 2002 | 83 | 12% | — | ||
35Molecular Aspects of MedicineElsevier BV · United Kingdom | 2.74Q1 | 5.52 1.55 down from 2002 | 31 | 0% | $5,220 | ||
36Mutation Research/Reviews in Mutation ResearchElsevier BV · Netherlands | 2.73Q1 | 6.37 0.43 down from 2002 | 100 | 5% | $4,160 | ||
37Applied and Environmental MicrobiologyOAAmerican Society for Microbiology · United States | 2.71Q1 | 4.45 0.43 up from 2002 | 2,692 | 98% | — | ||
38DevelopmentThe Company of Biologists · United Kingdom | 2.65Q1 | 8.53 0.22 down from 2002 | 1,498 | 40% | — | ||
39Analytical ChemistryAmerican Chemical Society · United States | 2.65Q1 | 4.21 0.72 up from 2002 | 3,362 | 8% | $4,500 | ||
40Arteriosclerosis Thrombosis and Vascular BiologyLippincott Williams & Wilkins · United States | 2.62Q1 | 6.65 0.52 up from 2002 | 1,136 | 49% | — | ||
41Molecular Biology and EvolutionOAOxford University Press · United States | 2.54Q1 | 6.05 0.94 up from 2002 | 716 | 67% | $3,418 | ||
42Physiological ReviewsAmerican Physiological Society · United States | 2.48Q1 | 41.54 13.40 up from 2002 | 107 | 11% | — | ||
43Critical Reviews in Analytical ChemistryTaylor & Francis · United States | 2.43Q1 | 3.07 0.99 up from 2002 | 43 | 0% | — | ||
44The FASEB JournalWiley · United States | 2.42Q1 | 6.17 0.59 up from 2002 | 1,447 | 7% | $3,740 | ||
45DNA ResearchOAUniversity of Oxford · United Kingdom | 2.42Q1 | 6.45 0.45 up from 2002 | 109 | 100% | $1,400 | ||
46Nucleic Acids ResearchOAOxford University Press · United Kingdom | 2.40Q1 | 7.59 0.82 up from 2002 | 2,395 | 99% | $3,992 | ||
47Molecular MicrobiologyWiley · United Kingdom | 2.37Q1 | 5.62 0.24 down from 2002 | 1,660 | 58% | $4,430 | ||
48Journal of Cell ScienceThe Company of Biologists · United Kingdom | 2.37Q1 | 6.86 0.40 up from 2002 | 1,551 | 20% | — | ||
49BMC BioinformaticsOABioMed Central · United Kingdom | 2.34Q1 | 6.45 1.25 up from 2002 | 50 | 100% | $2,990 | ||
50NeoplasiaOAElsevier BV · United Kingdom | 2.31Q1 | 4.22 2.46 down from 2002 | 173 | 100% | $3,530 |
Subfields of Biochemistry, Genetics and Molecular Biology, compared.
- Molecular Biology626
- Genetics68
- Cancer Research16
- Cell Biology14
- Biophysics6
- Molecular Medicine5
- Biochemistry2
- Clinical Biochemistry2
- Aging1
- Developmental Biology1
- Structural Biology1
- Biotechnology0
- Endocrinology0
- Physiology0
Journals
Citations made in 2003. Corpus-wide, 70.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
211 additional Biochemistry, Genetics and Molecular Biology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2000–2002, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2003. Publication window: 2000–2002. How these summaries are calculated
- Ranked journals
- 742
- Window papers (baseline)
- 375,343 +20.7% from indicator year 2000
- Median OJR
- 0.76 +21.6% from indicator year 2000
- Rising journals (2025)
- 141Comparison-group list (141)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2000–2002 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 609 | 650 | 696 | 742 | 765 | 806 | 835 | 888 | 919 | 951 | 1,003 | 1,064 | 1,125 | 1,172 | 1,217 | 1,271 | 1,311 | 1,339 | 1,365 | 1,369 | 1,349 | 1,339 | 1,358 | 1,366 | 1,355 | 1,367 | |
| Window papers (baseline) | 310,927 | 335,262 | 354,210 | 375,343 | 388,415 | 415,247 | 441,606 | 472,036 | 497,712 | 532,780 | 565,943 | 595,190 | 615,359 | 631,115 | 652,778 | 672,042 | 683,714 | 684,441 | 678,826 | 679,352 | 690,127 | 717,801 | 750,552 | 768,440 | 764,327 | 768,613 | |
| Median OJR | 0.628 | 0.634 | 0.68 | 0.76 | 0.81 | 0.8465 | 0.872 | 0.894 | 0.921 | 0.95 | 0.98 | 1.03 | 1.02 | 0.990 | 0.986 | 0.97 | 0.96 | 0.93 | 0.925 | 0.915 | 0.912 | 0.90 | 0.890 | 0.8474 | 0.853 | 0.871 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 1,206 journals |
| Retracted papers per 1,000 | Pooled rate: 4.798 per 1,000 | 1,059 journals |
| Output growth | Median: -6.4% | 1,233 journals |
| Open access share | Median: 100.0% | 1,367 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,300 | 943 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 24.4% | 1,335 journals |
| Review share | Median: 0.3% | 1,367 journals |
| Articles-only OJR | Median: 0.87 | 1,336 journals |
| Uncited share | Median: 22.7% | 1,367 journals |
| Citation concentration | Median: 42.1% | 1,363 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.